Quel est l'apport des nouvelles données des essais cliniques?: Quelles leçons pour la prise en charge des patients?
Passeron, Thierry; Boulinguez, Serge.
Ann Dermatol Venereol
; 137(5 Suppl 1): 11-5, 2010 May.
Artigo em Francês | MEDLINE | ID: mdl-20510174
Survival rates of biological therapies for psoriasis treatment in real-world clinical practice: A Canadian multicentre retrospective study.
Antidrug antibodies in psoriasis: a systematic review.
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris.
Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response.
Biologic drug survival in Israeli psoriasis patients.
Persistency of Biologic Therapies for Plaque Psoriasis in 2 Large Community Practices.
Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users.
Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
Interventions for nail psoriasis.
Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.